Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

被引：0
|
作者：
Paola Ponzani
Cesare Berra
Alessandra Di Lelio
Paola Del Sindaco
Chiara Di Loreto
Francesco Reggiani
Giuseppe Lucisano
Maria Chiara Rossi
机构：
[1] SSD Endocrinologia,
[2] Diabetologia e Malattie Metaboliche ASL3 Genovese,undefined
[3] Humanitas Research Institute,undefined
[4] CORESEARCH,undefined
[5] Center for Outcomes Research and Clinical Epidemiology,undefined
[6] Servizio di Diabetologia del Perugino USL Umbria 1,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Add-on; Effectiveness; Glycemic variability; Hypoglycemia; Insulin degludec; Real-world data; Switch; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2209 / 2218
页数：9
相关论文
共 50 条
  • [1] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    [J]. DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [2] Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    [J]. DIABETES THERAPY, 2020, 11 (01) : 97 - 105
  • [3] Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    [J]. Diabetes Therapy, 2020, 11 : 97 - 105
  • [4] Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting
    Jendle, J. H.
    Thunander, M.
    Sjoberg, S.
    Ekman, B.
    Mardby, A. -C.
    Fernandes, J. Da Rocha
    Gundgaard, J.
    Ericsson, A.
    [J]. DIABETOLOGIA, 2019, 62 : S436 - S436
  • [5] The effect of insulin degludec in people with type 2 diabetes in real-world clinical practice in China
    Zhu, D.
    Chang, X.
    Lehrskov, L. L.
    Li, L.
    Nordentoft, M.
    Quan, J.
    Sha, Y.
    Xing, Z.
    Yang, C.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [6] Real-World Assessment of Clinical Effectiveness when Switching to Insulin Degludec from Another Basal Insulin among Type 2 Diabetes Patients in the US
    Tibaldi, Joseph M.
    Hansen, Brian B.
    Wolden, Michael L.
    Moralea, Maria E.
    Yue, Yinan
    Weatherall, James
    Rodbard, Helena W.
    [J]. DIABETES, 2017, 66 : A261 - A261
  • [7] Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population
    Kochar, Inderpal Singh
    Sethi, Aashish
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2018,
  • [8] Effectiveness of Insulin Degludec in Thai Patients with Diabetes Mellitus: Real-World Evidence From a Specialized Diabetes Center
    Thewjitcharoen, Yotsapon
    Yenseung, Nalin
    Malidaeng, Areeya
    Butadej, Siriwan
    Chotwanvirat, Phawinpon
    Krittiyawong, Sirinate
    Thammawiwat, Chattip
    Himathongkam, Thep
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (09) : 666 - 673
  • [9] Switching to insulin degludec (IDeg) improves glycaemic control in patients with Type 2 diabetes in a real-world setting
    Feher, M.
    Tentolouris, N.
    Knudsen, S.
    Lapolla, A.
    Prager, R.
    Phan, T. M.
    Wolden, M. L.
    Schultes, B.
    [J]. DIABETIC MEDICINE, 2018, 35 : 203 - 203
  • [10] Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data
    Kaku, Kohei
    Wolden, Michael Lyng
    Hyllested-Winge, Jacob
    Nortoft, Emil
    [J]. DIABETES THERAPY, 2017, 8 (01) : 189 - 195
12345